PASADENA, Calif., Sept. 19, 2019 /PRNewswire/ -- The world-class surgeons at Eyesthetica have been featured in Pasadena Magazine, honored among the top health practitioners of 2019. As the largest oculofacial surgery practice dedicated to eyelid and facial surgery in the Los Angeles area, Eyesthetica promises patients natural-looking, youthful, and re

INDIANAPOLIS, Sept. 19, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will conduct a webcast on Wednesday, October 2, 2019 to discuss the company's presentations at the 2019 European Society for Medical Oncology (ESMO) Congress in Barcelona, Spain. Remarks will focus primarily on data being pres

WARSAW, Ind., Sept. 19, 2019 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced a multinational distribution agreement with Align Technology, Inc. (NASDAQ: ALGN), for the award-winning iTero Element family of intraoral scanners. Terms of the agreement have not been disclosed. The agreement expa

SECAUCUS, N.J., Sept. 19, 2019 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has received the 2019 Best Employers: Excellence in Health & Well-Being award, presented by the National Business Group on Health, a non-profit association of more than 440 large U.S. employer

BOSTON, Sept.19, 2019 /PRNewswire/ -- Proteostasis Therapeutics, Inc. (NASDAQ: PTI), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic fibrosis (CF) and other diseases caused by dysfunctional protein processing, today announced that Proteostasis management will present at the UK Cystic Fibrosis Conference (UKCFC) on

TORRANCE, Calif., Sept. 19, 2019 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTC: EMMA), a leader in sickle cell disease treatment, today announced the withdrawal of its marketing authorization application (MAA) to the European Medicines Agency (EMA) for Xyndari™ (glutamine) for the treatment of sickle cell disease.Xyndari was approved under the

CHICAGO, Sept. 19, 2019 /PRNewswire/ -- Hillrom (NYSE: HRC), will host its fiscal fourth quarter 2019 earnings conference call and webcast on Friday, November 1, 2019, beginning at 7:00 a.m. (CT) / 8:00 a.m. (ET).

CHICAGO, Sept. 19, 2019 /PRNewswire/ -- When you reduce stress through mindfulness, you improve productivity and decrease healthcare costs, according to data presented today at The Integrated Benefits Institute and Conference Board Health and Productivity Forum in Chicago.

DEER PARK, N.Y., Sept. 19, 2019 /PRNewswire/ -- DenseBreast-info.org (DB-I) today announced that it will host the second annual #DenseBreastDay on September 2

VIENNA, Va., Sept. 19, 2019 /PRNewswire/ -- Many healthcare professionals are starting to give more attention to Aspirin-Exacerbated Respiratory Disease (AERD), a chronic medical condition that involves asthma, persistent nasal polyps and a sensitivity to aspirin or other non-steroidal anti-inflammatory drugs (NSAID). As part of raising awareness of AERD, Allergy &a